EIOC 2025 Kicks Off in Dubai, Advancing Global Cancer Care

Dubai, UAE : The Excellence in Oncology Care Conference (EIOC 2025) officially opened today at the InterContinental Hotel, Dubai Festival City, welcoming more than 2,000 oncologists, researchers, and healthcare professionals from around the globe. Over the next three days, the conference will serve as a premier platform in the Middle East for fostering innovation, knowledge exchange, and international collaboration in cancer research and treatment.

EIOC 2025 aims to drive advancements in oncology by showcasing groundbreaking scientific discoveries, promoting evidence-based practices, and encouraging partnerships that enhance cancer prevention, early diagnosis, and treatment outcomes worldwide. The event has become a pivotal forum for advancing cancer care across the region.

This year’s conference brings together 30 specialized organizations, over 200 global experts, and 14 scientific sessions, offering participants an expansive platform to explore the latest innovations, research findings, and clinical practices that are shaping the future of oncology.

Leadership Insights
Dr. Abdulsalam AlMadani, Chairman of INDEX Holding, remarked:
"EIOC 2025 reflects our dedication to healthcare excellence and innovation in oncology. By convening top experts, researchers, and emerging talent, we provide a platform for collaboration, knowledge sharing, and the development of solutions that will redefine cancer care in the region and globally."

Dr. Shaheenah Dawood, President of the EIOC Conference, added:
"EIOC 2025 offers unmatched insights into integrated oncology care, digital health innovations, AI-driven diagnostics, and precision medicine. By merging research, technology, and emerging talent, we are shaping the future of cancer treatment and improving patient outcomes worldwide."

Scientific Agenda Highlights
The first day of EIOC 2025 featured a comprehensive scientific program addressing key challenges and breakthroughs in oncology:

• Breast Cancer: Sessions covered targeted therapies, early detection biomarkers, and precision medicine approaches to improve survival rates and reduce recurrence.

• Lung Cancer: Experts explored immunotherapy advances, molecular profiling, and minimally invasive diagnostics transforming patient care.

• Uro-Oncology: Panels focused on evolving treatments for prostate, bladder, and kidney cancers, highlighting genomics and personalized medicine.

• Oncology Nutrition: Presentations emphasized the critical role of nutrition in enhancing treatment tolerance, outcomes, and mitigating therapy side effects.

• Oncology Nursing: Discussions highlighted the role of nurses in patient-centered care, symptom management, and psychosocial support.

• Palliative Care: Specialists shared best practices in holistic care, pain management, and end-of-life decision-making.

A key feature of the conference is the APMEA Molecular Tumor Board (MTB), a collaborative global platform where multidisciplinary experts analyze complex cancer cases using genomic and molecular insights to guide optimal treatment strategies.

The Young Leaders in Oncology (YLO) session also stood out, offering a dynamic platform for emerging oncology professionals to showcase pioneering research, innovative methods, and impactful case studies. The session included competitive elements, recognizing outstanding presentations and encouraging participants to deliver their most influential work.

Through these sessions, EIOC 2025 highlights the transformative role of research, technology, and emerging talent in advancing integrated oncology care, AI-powered diagnostics, and precision medicine globally.

Organizers & Supporters
EIOC 2025 is organized by INDEX Conferences and Exhibitions Org., a member of INDEX Holding, and is supported by key institutions including the Dubai Health Authority, Arab Association of Urology, Arab School of Urology, International Federation of Head and Neck Oncologic Societies, and the Emirates Oncology & Hematology Nursing Society.